| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-12 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.28 | 1e-09 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.25 | 5e-07 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.27 | 9e-06 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.24 | 2e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |